Page last updated: 2024-10-28

hexamethonium and Allodynia

hexamethonium has been researched along with Allodynia in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albers, KM1
Zhang, XL1
Diges, CM1
Schwartz, ES1
Yang, CI1
Davis, BM1
Gold, MS1
Kanashiro, A1
Talbot, J1
Peres, RS1
Pinto, LG1
Bassi, GS1
Cunha, TM1
Cunha, FQ1

Other Studies

2 other studies available for hexamethonium and Allodynia

ArticleYear
Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons.
    Molecular pain, 2014, May-22, Volume: 10

    Topics: Animals; Female; Ganglia, Spinal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic F

2014
Neutrophil Recruitment and Articular Hyperalgesia in Antigen-Induced Arthritis are Modulated by the Cholinergic Anti-Inflammatory Pathway.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:5

    Topics: Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; Atropine Derivatives; Cholinergic

2016